Global CT Guided Biopsy Market Size, Share & Forecast 2033

The worldwide market for specialized tools, supplies, and procedural processes used in needle-based tissue sampling performed under real-time or near-real-time Computed Tomography (CT) imaging guidance is included in the CT-guided biopsy market. Core needle biopsy systems, coaxial needles, fine-needle aspiration instruments, and sophisticated guiding platforms that work with conventional CT, CT-fluoroscopy, cone-beam CT, and newly developed spectral/dual-energy CT modalities are all included. Accurate localization of lesions in organs like the liver, lungs, and bones is made possible by CT-guided biopsy techniques, which improve diagnostic precision for diseases like cancer and infectious disorders. In July 2025, Australia\'s National Lung Cancer Screening Program (NLCSP), which was launched, offers bulk-billed low-dose CT scans to high-risk persons aged 50–70, is one of the major government initiatives driving growth. It greatly increases the number of follow-up CT-guided biopsies performed for found nodules. One major factor is the growing prevalence of chronic illnesses and cancer